You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 22, 2024

Triamcinolone acetonide - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for triamcinolone acetonide and what is the scope of freedom to operate?

Triamcinolone acetonide is the generic ingredient in twenty-seven branded drugs marketed by Abbvie, Chattem Sanofi, Astellas, Ivax Pharms, Delcor Asset Corp, Teva, Solvay, Actavis Mid Atlantic, Alkem Labs Ltd, Alpharma Us Pharms, Ambix, Chartwell Rx, Cosette, Encube, Fougera Pharms, Glenmark Pharms Ltd, Macleods Pharms Ltd, Micro Labs, Morton Grove, Mylan, Padagis Us, Pharmaderm, Pharmafair, Strides Pharma, Taro, Topiderm, Crown Labs, Savage Labs, Pacira Pharms Inc, Apothecon, Amneal, Eugia Pharma, Long Grove Pharms, Mylan Labs Ltd, Parnell, Sandoz, Teva Pharms Usa, Watson Labs, Allergan, Harrow Eye, Epic Pharma Llc, Pai Holdings Pharm, Quagen, Wockhardt Bio Ag, Aurobindo Pharma Ltd, Cintex Svcs, Glenmark Pharms, Padagis Israel, Cmp Pharma Inc, Akorn, Lyne, Lupin Atlantis, Sanofi Aventis Us, Apotex, Perrigo Pharma Intl, Sun Pharm Inds Inc, Rising, Saptalis Pharms, and Bausch And Lomb Inc, and is included in one hundred and thirty-nine NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Triamcinolone acetonide has one hundred and fifty-seven patent family members in twenty-nine countries.

There are twenty-six drug master file entries for triamcinolone acetonide. Sixty-nine suppliers are listed for this compound.

Drug Prices for triamcinolone acetonide

See drug prices for triamcinolone acetonide

Drug Sales Revenue Trends for triamcinolone acetonide

See drug sales revenues for triamcinolone acetonide

Recent Clinical Trials for triamcinolone acetonide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Gadjah Mada UniversityPhase 1/Phase 2
Innovaderm Research Inc.Phase 4
Centre hospitalier de l'Université de Montréal (CHUM)Phase 4

See all triamcinolone acetonide clinical trials

Pharmacology for triamcinolone acetonide
Medical Subject Heading (MeSH) Categories for triamcinolone acetonide

US Patents and Regulatory Information for triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Savage Labs TRYMEX triamcinolone acetonide CREAM;TOPICAL 088197-001 Mar 25, 1983 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Aurobindo Pharma Ltd TRIAMCINOLONE ACETONIDE triamcinolone acetonide OINTMENT;TOPICAL 211315-001 Mar 18, 2020 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Encube TRIAMCINOLONE ACETONIDE triamcinolone acetonide OINTMENT;TOPICAL 205373-001 May 13, 2016 AT RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Delcor Asset Corp KENALOG triamcinolone acetonide LOTION;TOPICAL 011602-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Chattem Sanofi NASACORT ALLERGY 24 HOUR triamcinolone acetonide SPRAY, METERED;NASAL 020468-002 Oct 11, 2013 ⤷  Try a Trial ⤷  Try a Trial
Chattem Sanofi NASACORT triamcinolone acetonide AEROSOL, METERED;NASAL 019798-001 Jul 11, 1991 ⤷  Try a Trial ⤷  Try a Trial
Delcor Asset Corp KENALOG-H triamcinolone acetonide CREAM;TOPICAL 086240-001 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
Abbvie AZMACORT triamcinolone acetonide AEROSOL, METERED;INHALATION 018117-001 Apr 23, 1982 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for triamcinolone acetonide

Country Patent Number Title Estimated Expiration
Israel 238432 שיטות ומכשירים לטיפול במחלות עיניים בבני-אדם (Methods and devices for the treatment of ocular diseases in human subjects) ⤷  Try a Trial
Spain 2642312 ⤷  Try a Trial
Japan 5873492 ⤷  Try a Trial
Australia 2011285691 Corticosteroids for the treatment of joint pain ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.